July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Titration for selective RPE therapy using a continuous line scanning laser
Author Affiliations & Notes
  • Mohajeet Balveer Bhuckory
    Ophthalmology, Stanford University, Stanford, California, United States
  • Thomas Flores
    Applied physics, Stanford University, California, United States
  • xiaozhuo shao
    Topcon Medical Systems, Inc., California, United States
  • Roopa Dalal
    Ophthalmology, Stanford University, Stanford, California, United States
  • Daniel V Palanker
    Ophthalmology, Stanford University, Stanford, California, United States
  • Footnotes
    Commercial Relationships   Mohajeet Bhuckory, None; Thomas Flores, None; xiaozhuo shao, Topcon Medical Systems, Inc. (E); Roopa Dalal, None; Daniel Palanker, Topcon Medical Systems, Inc. (F), Topcon Medical Systems, Inc. (C), Topcon Medical Systems, Inc. (P)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 3674. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mohajeet Balveer Bhuckory, Thomas Flores, xiaozhuo shao, Roopa Dalal, Daniel V Palanker; Titration for selective RPE therapy using a continuous line scanning laser. Invest. Ophthalmol. Vis. Sci. 2019;60(9):3674.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Selectively damaging a fraction of RPE cells in aged eyes using short-pulse laser could provide benefits associated with RPE rejuvenation. However, variation in pigmentation within the eye and between different subjects results in inconsistent damage threshold. We propose a titration-based method to determine the therapeutic window prior to treatment. This approach could enable patient-specific laser parameters for targeting RPE without damaging photoreceptors.

Methods : A Pascal Synthesis 577nm laser was used to induce RPE damage in pigmented rabbits (Dutch Belted). Titration was performed in the treatment area by adjusting the laser power to produce a barely visible retinal lesion with a 200 μm diameter spot and 20 ms pulse duration. The line scanning treatment was delivered using 100 μm diameter spot, along 2mm length, at 6 m/s velocity, with 3 repeats applied at 10 Hz, within power range of 0.6-2 W. The RPE and photoreceptor damage were evaluated at days 0 (D0), 1 (D1) and 7 (D7) after treatment using OCT, fluorescein angiography (FA) and scanning electron microscopy (SEM). The RPE and photoreceptor damage thresholds were plotted against the titration damage thresholds to produce an algorithm predicting the appropriate laser power to use.

Results : RPE damage was observed by the increase in fluorescein intensity with increasing power right after treatment. 1 day after laser, fluorescein leakage from the choroidal circulation was still visible, but had completely subsided by day 7, indicating a recovery of the outer blood retinal barrier. RPE damage was confirmed on SEM by an absence of RPE cells within the line scan area at D1, exposing the Bruch’s membrane. The RPE cells had repopulated the lasered area by D7. OCT imaging revealed the laser powers that induced photoreceptor loss. The titration damage thresholds were correlated with the RPE and photoreceptor damage thresholds and a titration algorithm was derived.

Conclusions : The rejuvenation of RPE based on migration and proliferation of cells observed after line scanning treatment could be used for treatment of diseases associated with RPE dysfunction. The titration algorithm provides a predictable and patient-specific laser dosimetry, targeting RPE cells without causing damage to the overlaying photoreceptor cells.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×